Seminars in Radiation Oncology

Papers
(The median citation count of Seminars in Radiation Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Global Workforce and Access: Demand, Education, Quality59
The seemingly contradictory roles of radiation as focal to systemic therapy in hematologic malignancies53
Spatially Fractionated Radiotherapy in the Era of Immunotherapy44
Artificial Intelligence for Radiation Oncology Applications Using Public Datasets31
The Quality Assurance of a 1.5 T MR-Linac29
Extremity and Truncal Soft Tissue Sarcoma: Risk Assessment and Multidisciplinary Management28
Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer28
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy Approach26
Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology26
Rectal Cancer MRI Guided Radiotherapy: A Practical Review for the Physician26
Are We Ready for Life in the Fast Lane? A Critical Review of Preoperative Hypofractionated Radiotherapy for Localized Soft Tissue Sarcoma24
[18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription24
How Small Can We Go? Partial Bladder Radiation Therapy and Brachytherapy24
Integrating the Patient's Voice in Toxicity Reporting and Treatment Decisions for Breast Radiotherapy23
Artificial Intelligence for Outcome Modeling in Radiotherapy20
The Role of Radiation Therapy for Palliation of Hematologic Malignancies19
Radiation Therapy for Painful Bone Metastases: Fractionation, Recalcification, and Symptom Control18
The Role of Radiotherapy in Lymphoma Patients Undergoing CAR T Therapy: Past, Present, and Future18
Introduction: Personalization of Cancer Care for Older Adults18
Novel biomarkers for guiding treatment for prostate cancer18
Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology17
Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon15
Radiotherapy Combined with Intralesional Immunostimulatory Agents for Soft Tissue Sarcomas15
Intrafraction Motion Management With MR-Guided Radiation Therapy15
Treatment De-intensification for HPV-associated Oropharyngeal Cancer: A Definitive Surgery Paradigm13
Novel Survivorship Paradigms in Head/Neck Cancer13
Uncertainty Assessment for Deep Learning Radiotherapy Applications12
Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions12
Myths About Bladder Preservation in Muscle-Invasive Bladder Cancer12
Targeting Noncanonical Regulators of the DNA Damage Response to Selectively Overcome Cancer Radiation Resistance12
De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions12
The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization11
Biology of HPV Mediated Carcinogenesis and Tumor Progression11
Optimizing Informed Consent in Cancer Clinical Trials11
The Role of Radiotherapy in Hematologic Malignancies in Children, Adolescents, and Young Adults10
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck10
Advances in Automated Treatment Planning10
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy10
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity10
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer9
Advancing Prostate Cancer Treatment: A Review of CT and MR-Guided Online Adaptive Radiotherapy Techniques9
Early-stage Breast Cancer: Tailored External Beam Fractionation Approaches for Treatment of the Whole or Partial Breast9
Advances and Challenges in Conducting Clinical Trials With Proton Beam Therapy9
Optimizing GRID and Lattice Spatially Fractionated Radiation Therapy: Innovative Strategies for Radioresistant and Bulky Tumor Management9
MRI-Guided Radiation Therapy—An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations8
Brain Metastases: Is There Still a Role for Whole-Brain Radiation Therapy?8
Green Horizons in Oncology: A Blueprint for Environmentally Sustainable Radiation Therapy Facilities8
Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care8
The Use of Particle Therapy in Prostate Cancer8
Radiation Sensitivity: The Rise of Predictive Patient-Derived Cancer Models8
Hypofractionation in Older Adults With Glioblastoma8
Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology8
The History and Future of Multidisciplinary Cancer Care7
Optimizing Radiation Therapy for Localized Prostate Cancer: Exploring Synergies With Androgen Deprivation Therapy and Novel Systemic Agents7
The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance7
Advancing Towards Personalized Prescription of Radiotherapy Dose7
Democratizing FLASH Radiotherapy7
Lessons and Opportunities for Biomarker-Driven Radiation Personalization in Head and Neck Cancer6
Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice6
The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity6
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications6
Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions6
MRI-Guided Adaptive Radiation Therapy6
Theranostics and Patient-Specific Dosimetry6
Radiotherapy Dose in Patients Receiving Immunotherapy6
Hypoxia-Targeted Dose Painting in Radiotherapy5
Managing Patients with Head and Neck Cancer and Advanced Age or Comorbidities5
Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-835
Harnessing the DNA Repair Pathway in Breast Cancer: Germline Mutations/Polymorphisms in Breast Radiation5
Prevention and Screening of HPV Malignancies5
Personalization of Radiation Therapy in the Primary Treatment of Malignant Epidural Spinal Cord Compression (MESCC)5
Modern Treatment Delivery of Radiotherapy for Lymphomas and Leukemias: Making Every Gy Count5
Radiation-Therapy Related Salivary Dysfunction5
De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches5
Integration of Radiation and Reconstruction After Mastectomy5
Chromosome Missegregation as a Modulator of Radiation Sensitivity5
Debate 1: Radical Prostatectomy For the Right Patient With High-Risk Prostate Cancer4
Oncometabolites as Regulators of DNA Damage Response and Repair4
The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy4
Oral Mucositis in Head and Neck Cancer Patients4
The Use of MR-Guided Radiation Therapy for Liver Cancer4
Radiation Therapy in the Management of Adrenal Metastases4
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV Status4
Editorial4
Emerging Technologies in Mitigating the Risks of Cardiac Toxicity From Breast Radiotherapy4
Future of Multidisciplinary Team in the Context of Adaptive Therapy4
The Future of Education in Radiation Oncology4
MRgRT Quality Assurance for a Low-Field MR-Linac4
The Future of Safety and Quality in Radiation Oncology4
Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations4
The Biological Process of Aging and the Impact of Ionizing Radiation4
Radiotherapy for High-Risk Prostate Cancer3
Quality Assurance for AI-Based Applications in Radiation Therapy3
Standardization of Artificial Intelligence Development in Radiotherapy3
The contemporary spectrum of radiotherapy for hematologic malignancies involving the central nervous system: From focal therapy to craniospinal3
Recognizing Frailty in Radiation Oncology Clinical Practice: Current Evidence and Future Directions3
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer3
Immunotherapy for HPV Malignancies3
Debate 2: Primary Localized Prostate Cancer: The Case for Whole-Gland Brachytherapy Boost3
Advancing the Collaboration Between Imaging and Radiation Oncology3
Exploring the Advantages and Challenges of MR-Guided Radiotherapy in Non–Small-Cell Lung Cancer: Who are the Optimal Candidates?3
Radiation Therapy in Node-Positive Prostate Cancer: Current Evidence and Future Directions3
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas3
Head and Neck Cancer of Unknown Primary: A Surgical Perspective3
Radiopharmaceuticals in Prostate Cancer: General Considerations and Utility in Combination With EBRT3
Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?3
Elective Regional Nodal Irradiation in Prostate Cancer3
Prognostic and Predictive Clinical and Biological Factors in HPV Malignancies3
A Partial Tumor Irradiation Approach for Complex Bulky Disease3
Artificial Intelligence for Image Registration in Radiation Oncology3
MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing3
The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease3
Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making3
Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas3
0.036576986312866